MELPHALAN PREDNISONE VERSUS MELPHALAN PREDNISONE PLUS HUMAN ALPHA INTERFERON THERAPY IN PATIENTS WITH MULTIPLE-MYELOMA, STAGE-II AND STAGE-III

被引：2

作者：

BJORKHOLM, M

MELLSTEDT, H

OSTERBORG, A

BJOREMAN, M

LERNER, R

MERK, K

BRENNING, G

OHRLING, M

GAHRTON, G

SIMONSSON, B

GRIMFORS, G

SMEDMYR, B

GYLLENHAMAR, H

STALFELT, A

HAST, R

STRANDER, H

JULIUSSON, G

SVEDMYR, E

JARNMARK, M

UDEN, A

KILLANDER, A

WADMAN, B

KIMBY, E

OSBY, E

机构：

[1] Department of Medicine, Karolinska Hospital, Stockholm

来源：

EUROPEAN JOURNAL OF CANCER | 1991年 / 27卷

关键词：

D O I：

10.1016/0277-5379(91)90574-W

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：S51 / S52

页数：2

共 7 条

[1]

AHRE A, 1984, CANCER TREAT REP, V68, P1331

[2]

ALEXANIAN R, 1982, CLIN HAEMATOL, V11, P211

[3] RECOMBINANT INTERFERON ALFA-2C VERSUS POLYCHEMOTHERAPY (VMCP) FOR TREATMENT OF MULTIPLE-MYELOMA - A PROSPECTIVE RANDOMIZED TRIAL [J].

LUDWIG, H ;

CORTELEZZI, A ;

SCHEITHAUER, W ;

VANCAMP, BGK ;

KUZMITS, R ;

FILLET, G ;

PEETERMANS, M ;

POLLI, E ;

FLENER, R .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (09) :1111-1116

[4]

MELLSTEDT H, 1982, IMMUNOTHERAPY HUMAN, P387

[5]

OHNO R, 1987, INT J CANCER S1, V1, P14

[6]

QUESADA JR, 1986, BLOOD, V67, P275

[7] COMBINED RECOMBINANT HUMAN INTERFERON ALPHA-2 AND CYTO-TOXIC AGENTS STUDIED IN A CLONOGENIC-ASSAY [J].

WELANDER, CE ;

MORGAN, TM ;

HOMESLEY, HD ;

TROTTA, PP ;

SPIEGEL, RJ .

INTERNATIONAL JOURNAL OF CANCER, 1985, 35 (06) :721-729

← 1 →